uPA activators include various compounds that indirectly enhance the functional activity of uPA, a protease integral to extracellular matrix degradation and cell migration. These activators function by modulating signaling pathways and cellular processes crucial for uPA's role. In addition to growth factors, cytokines involved in inflammation and immune responses can also upregulate uPA expression. Compounds that influence the extracellular matrix composition, such as collagen, or those involved in the fibrinolytic system, like fibrinogen and plasminogen, can impact uPA activity.
The interaction between uPA and these matrix components is key in processes like tissue repair, angiogenesis, and cancer metastasis. Furthermore, inhibitors of related proteases or components of the coagulation cascade can lead to compensatory mechanisms that enhance uPA activity. This indirect activation approach underscores the complex regulation of uPA in physiological and pathological processes, highlighting its importance in tissue remodeling, wound healing, and cancer progression. By targeting various signaling components and cellular processes associated with uPA, these activators provide insights into the modulation of key proteolytic enzymes and their implications in health and disease.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Gefitinib | 184475-35-2 | sc-202166 sc-202166A sc-202166B sc-202166C | 100 mg 250 mg 1 g 5 g | $62.00 $112.00 $214.00 $342.00 | 74 | |
An EGF receptor inhibitor, Gefitinib can lead to compensatory upregulation of uPA expression in certain cancer cells. | ||||||
Pirfenidone | 53179-13-8 | sc-203663 sc-203663A | 10 mg 50 mg | $100.00 $408.00 | 6 | |
Used in treating fibrosis, Pirfenidone may modulate TGF-β activity, potentially influencing uPA expression in tissue remodeling. | ||||||
Imatinib mesylate | 220127-57-1 | sc-202180 sc-202180A | 25 mg 100 mg | $44.00 $109.00 | 61 | |
A PDGF receptor inhibitor, Imatinib can affect wound healing processes, potentially influencing uPA expression. | ||||||
Anakinra | 143090-92-0 | sc-507486 | 10 mg | $795.00 | ||
An IL-1 receptor antagonist, Anakinra may impact uPA expression in inflammatory and immune response pathways. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
A multi-kinase inhibitor, Sorafenib can affect various signaling pathways, potentially leading to changes in uPA expression in cancer cells. | ||||||
Tranilast | 53902-12-8 | sc-200389 sc-200389A sc-200389B sc-200389C | 10 mg 50 mg 1 g 5 g | $30.00 $101.00 $277.00 $959.00 | 2 | |
Used for its anti-allergic properties, Tranilast may influence uPA expression through its effects on inflammatory pathways. | ||||||
Zoledronic acid, anhydrous | 118072-93-8 | sc-364663 sc-364663A | 25 mg 100 mg | $90.00 $251.00 | 5 | |
Used in bone diseases, Zoledronic Acid can affect bone remodeling processes, potentially influencing uPA activity. | ||||||